Skip to main content

Table 4 Systemic and coronary levels of CRP, MPO, sCD40L and PlGF in both CSA and ACS patients

From: Systemic and coronary levels of CRP, MPO, sCD40L and PlGF in patients with coronary artery disease

 

CRP (mg/L)

MPO (ng/mL)

sCD40L (ng/mL)

PlGF (pg/mL)

CSA

 Coronary

3.14 (1.60–6.40)

442.88 (256.38–525.20)

1.90 (1.34–3.77)

51.57 (8.85–81.66)

 Systemic

3.97 (2.39–8.38)

426.06 (351.28–511.93)

1.84 (0.90–3.15)

16.28 (6.63–36.44)

 p valuea

0.001*

0.192

0.038*

<0.001*

 Spearman’s ρ

0.904

0.427

0.433

0.663

 p valueb

<0.001*

0.006*

0.005*

<0.001*

ACS

 Coronary

16.34 (4.93–40.12)

608.75 (283.54–998.22)

3.19 (1.66–6.60)

53.43 (37.72–74.69)

 Systemic

22.03 (4.72–45.86)

529.53 (323.91–1015.33)

2.95 (1.31–7.14)

42.36 (23.72–59.54)

 p valuea

0.199

0.567

0.759

0.009*

 Spearman’s ρ

0.961

0.818

0.597

0.475

 p valueb

<0.001*

<0.001*

<0.001*

0.002*

  1. CRP C-reactive protein, MPO myeloperoxidase, sCD40L soluble CD40 ligand, PlGF placental growth factor
  2. Data were given as median (IQR)
  3. * Significant with p < 0.05
  4. a p: p value for the Wilcoxon signed-ranks test
  5. b p: p value of the correlation test